Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of CANX mRNA | affects expression | 21346803
|
C472791 |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in increased expression of CANX mRNA | increases expression | 16788091
|
D024502 |
alpha-Tocopherol |
alpha-Tocopherol affects the localization of CANX protein | affects localization | 16908007
|
D024502 |
alpha-Tocopherol |
alpha-Tocopherol results in increased expression of CANX mRNA | increases expression | 16908007
|
D024502 |
alpha-Tocopherol |
alpha-Tocopherol results in increased expression of CANX protein | increases expression | 16908007
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of CANX mRNA | affects expression | 16483693
|
D000643 |
Ammonium Chloride |
Ammonium Chloride results in decreased expression of CANX protein | decreases expression | 16483693
|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of CANX mRNA | increases expression | 20458559
|
C095105 |
bexarotene |
bexarotene results in increased expression of CANX mRNA | increases expression | 16648578
|
C110904 |
capecitabine |
CANX results in decreased susceptibility to [Fluorouracil co-treated with capecitabine] | affects cotreatment|decreases response to substance | 18678097
|
D002509 |
Cephaloridine |
Cephaloridine results in increased expression of CANX mRNA | increases expression | 18172885
|
D003520 |
Cyclophosphamide |
Cyclophosphamide results in decreased expression of CANX mRNA | decreases expression | 11906922
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of CANX mRNA | increases expression | 20106945
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of CANX mRNA | increases expression | 18172885
|
D016190 |
Carboplatin |
Carboplatin results in decreased expression of CANX mRNA | decreases expression | 18172885
|
D002945 |
Cisplatin |
Cisplatin results in decreased expression of CANX mRNA | decreases expression | 18246545
|
D004642 |
Emodin |
Emodin results in decreased expression of CANX mRNA | decreases expression | 16045814
|
C020326 |
ferric nitrilotriacetate |
ferric nitrilotriacetate results in increased expression of CANX protein | increases expression | 16908007
|
D005472 |
Fluorouracil |
CANX results in decreased susceptibility to [Fluorouracil co-treated with capecitabine] | affects cotreatment|decreases response to substance | 18678097
|
D005472 |
Fluorouracil |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of CANX mRNA] | affects reaction|decreases expression | 15016801
|
D005839 |
Gentamicins |
Gentamicins results in increased expression of CANX mRNA | increases expression | 18172885
|
D017313 |
Fenretinide |
Fenretinide results in increased expression of CANX protein | increases expression | 17353921
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of CANX mRNA | affects cotreatment|increases expression | 17183730
|
D015741 |
Metribolone |
Metribolone promotes the reaction [NDRG1 protein binds to CANX protein] | affects binding|increases reaction | 17220478
|
D009532 |
Nickel |
MT1 affects the reaction [Nickel affects the expression of CANX mRNA] | affects expression|affects reaction | 16166738
|
D009532 |
Nickel |
MT2 affects the reaction [Nickel affects the expression of CANX mRNA] | affects expression|affects reaction | 16166738
|
C029938 |
nickel sulfate |
nickel sulfate results in decreased expression of CANX mRNA | decreases expression | 16780908
|
D019284 |
Thapsigargin |
Thapsigargin results in increased expression of CANX protein | increases expression | 17353921
|
D014501 |
Uranium |
Uranium affects the expression of CANX mRNA | affects expression | 15672453
|
C005460 |
uranyl acetate |
uranyl acetate affects the expression of CANX mRNA | affects expression | 15672453
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of CANX mRNA | affects cotreatment|increases expression | 17183730
|
C025643 |
vinclozolin |
vinclozolin affects the expression of CANX mRNA | affects expression | 19015723
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
3.28 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.74 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.35 | 18287403 |
MESH:D058186 |
Acute Kidney Injury |
|
Cisplatin |
8.51 | 15814532 12690470 17670903 |
MESH:D058186 |
Acute Kidney Injury |
|
Gentamicins |
8.51 | 11274264 |
MESH:D055371 |
Acute Lung Injury |
|
Nickel |
9.03 | 16166738 |
MESH:D055371 |
Acute Lung Injury |
|
nickel sulfate |
9.03 | 11954676 12718980 19131640 16100012 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
9.82 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Cisplatin |
9.82 | 11798837 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Fenretinide |
9.82 | 10697514 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
9.82 | 17638652 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.02 | 17688650 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
3.53 | 15504547 17963324 16511603 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
8.31 | 17497229 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
8.31 | 19015723 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
4.39 | 15014928 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.02 | 17688650 19460635 16609825 18940202 18177632 20603192 18316065 19232924 17157402 18396377 18775368 18558336 17507914 15238991 18985861 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
2.97 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
3.48 | 16206674 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.27 | 8888407 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Cisplatin |
4.67 | 14601052 |
MESH:D001932 |
Brain Neoplasms |
|
Fenretinide |
4.17 | 16187019 |
MESH:D001943 |
Breast Neoplasms |
|
bexarotene |
3.65 | 16344269 16818667 |
MESH:D001943 |
Breast Neoplasms |
|
capecitabine |
3.65 | 18473752 12972520 |
MESH:D001943 |
Breast Neoplasms |
|
Cisplatin |
3.65 | 19526202 18382427 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
3.65 | 15136595 17388661 16978400 18323546 15093573 18234424 11325840 12006526 17020986 |
MESH:D001943 |
Breast Neoplasms |
|
Fenretinide |
3.65 | 16601279 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
3.65 | 16557594 16110121 18608205 16595493 19217205 18357371 15136595 |
MESH:D001943 |
Breast Neoplasms |
|
Nickel |
3.65 | 15986119 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.13 | 11589617 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
4.46 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
3.40 | 17121937 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
10.95 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
10.95 | 16217749 14691202 15073043 15553829 11135700 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cisplatin |
10.95 | 17982673 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
10.95 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fenretinide |
10.95 | 17159502 16270382 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
10.95 | 16332177 17088986 16799960 17971768 18930000 17045692 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
4.68 | 16152834 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
bexarotene |
8.81 | 16247446 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Carboplatin |
8.81 | 16685392 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Cisplatin |
8.81 | 12023789 16685392 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.66 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
10.50 | 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
ferric nitrilotriacetate |
10.50 | 8340253 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
10.50 | 18695887 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.93 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Cisplatin |
7.38 | 18337622 17066447 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fenretinide |
7.38 | 16274795 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
7.38 | 16757204 18986760 16280240 17066447 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.39 | 12371664 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Fenretinide |
5.26 | 16154183 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.63 | 20734317 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
2.76 | 19486331 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
2.20 | 16510598 17287894 17725105 17018589 15001691 17016597 17169374 18772588 16340194 17172411 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
6.29 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
capecitabine |
6.29 | 18473752 18448328 |
MESH:D015179 |
Colorectal Neoplasms |
|
Cisplatin |
6.29 | 15273666 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fenretinide |
6.29 | 17273769 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
6.29 | 16524972 18802399 18509181 16282729 20501625 17594712 17695437 18288408 14970324 18949393 15148649 16391804 16303861 18448328 17454858 15289873 16331619 17016601 17094418 17255274 17401013 18383874 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
3.98 | 12609071 |
MESH:D003329 |
Coronary Vasospasm |
|
capecitabine |
5.61 | 17465463 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
2.64 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
2.64 | 8888407 17688650 16575769 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.14 | 14966744 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
3.81 | 18551238 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
4.77 | 12913760 16413132 18433785 16989017 18372110 11948286 12388444 18093676 15276878 18710439 16614059 17010015 10498854 10700343 18295254 15643279 17979934 12161096 16651033 18483878 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.58 | 16733453 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.90 | 15213294 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Nickel |
6.88 | 19470301 17244072 17100760 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
nickel sulfate |
6.88 | 11298694 16823706 16780908 |
MESH:D003877 |
Dermatitis, Contact |
|
Nickel |
4.44 | 2952479 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
3.90 | 10990075 15331540 11751995 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.16 | 18772604 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
alpha-Tocopherol |
3.71 | 16506275 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
3.73 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
3.73 | 19641884 1733752 |
MESH:D004362 |
Drug Toxicity |
|
Cisplatin |
8.29 | 15033597 19839026 12649298 12231392 |
MESH:D004362 |
Drug Toxicity |
|
Gentamicins |
8.29 | 11033412 15033597 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
3.85 | 1851702 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
4.01 | 11006010 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
3.95 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.71 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.83 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.41 | 6426943 6254150 7562514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.09 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
3.85 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
7.04 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Cisplatin |
7.04 | 17638652 16785472 15173087 16481741 15464296 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
7.04 | 16481741 16785472 15173087 17638652 16337965 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
12.04 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
12.04 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
12.04 | 19224547 14986274 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.67 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
3.93 | 8888407 18558336 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.48 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Emodin |
8.48 | 19474275 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.06 | 16904648 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
4.72 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.09 | 16417039 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.01 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Fenretinide |
3.76 | 16187019 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.79 | 16145905 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.30 | 11389073 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
4.83 | 15172196 11014644 16376943 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Cisplatin |
7.52 | 15464296 15102660 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
7.52 | 15162350 18337622 15102660 |
MESH:D034381 |
Hearing Loss |
|
Cisplatin |
9.70 | 19898482 |
MESH:D034381 |
Hearing Loss |
|
Gentamicins |
9.70 | 17868369 19130971 18024279 15968427 |
MESH:D006319 |
Hearing Loss, Sensorineural |
|
Cisplatin |
4.25 | 15464296 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.21 | 15720958 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
5.08 | 11918545 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
5.32 | 14986274 |
MESH:D015658 |
HIV Infections |
|
Nickel |
3.71 | 17263646 |
MESH:D006689 |
Hodgkin Disease |
|
Cisplatin |
7.20 | 16200630 16170182 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
7.20 | 17606976 16135485 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.66 | 17688650 |
MESH:D053565 |
Hypercalciuria |
|
Gentamicins |
5.50 | 17652376 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.02 | 10903974 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.42 | 16612254 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
5.12 | 16076520 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
6.62 | 7193160 16517039 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
6.62 | 16467254 |
MESH:D007249 |
Inflammation |
|
Nickel |
3.32 | 16166738 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.23 | 15604871 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Cisplatin |
12.61 | 15464296 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Gentamicins |
12.61 | 18842672 |
MESH:D007674 |
Kidney Diseases |
|
Cisplatin |
13.61 | 12231392 18289764 15190930 12649298 19839026 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
13.61 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
ferric nitrilotriacetate |
13.61 | 18617210 15834431 |
MESH:D007674 |
Kidney Diseases |
|
Gentamicins |
13.61 | 18289764 19349640 17934191 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
16.44 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
16.44 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
ferric nitrilotriacetate |
16.44 | 18055543 9667754 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
16.44 | 16985049 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Cisplatin |
11.30 | 11231351 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Gentamicins |
11.30 | 11231351 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Gentamicins |
4.29 | 10219319 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
6.26 | 15070760 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
6.26 | 10602166 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.41 | 17296974 18587576 17008537 17802794 17658394 18172266 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
9.43 | 12560223 17077332 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Emodin |
9.43 | 17077332 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.10 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
8.11 | 14633726 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
8.11 | 10373061 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
3.57 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
3.78 | 17050201 20471514 16467208 16968895 19850784 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
3.78 | 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
3.08 | 16823087 11468182 17869043 12018890 15622746 19035177 12679006 16331271 17649720 16112521 12712474 17107899 19075265 11161223 19642359 15336539 9834237 16330433 15213294 15748426 16891316 16966277 17712046 19225113 17217047 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.15 | 16882451 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
4.75 | 10052129 11830472 |
MESH:D007972 |
Leukoplakia, Oral |
|
Fenretinide |
5.83 | 16707609 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.52 | 16417039 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Emodin |
3.09 | 15288473 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
4.46 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
4.46 | 18383874 16603448 15113037 17045692 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
2.61 | 20377131 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.19 | 15213294 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.05 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
alpha-Tocopherol |
6.36 | 16401635 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
6.36 | 19825857 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
bexarotene |
6.36 | 17849452 |
MESH:D008175 |
Lung Neoplasms |
|
Cisplatin |
6.36 | 6189445 11798837 17225452 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
6.36 | 15246190 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.58 | 15086387 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
3.69 | 12854902 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
4.40 | 16675587 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
4.00 | 11911406 |
MESH:D016410 |
Lymphoma, T-Cell, Cutaneous |
|
bexarotene |
4.94 | 11161223 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
bexarotene |
6.19 | 15591091 19196722 19196723 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Fenretinide |
6.19 | 10697514 |
MESH:D008545 |
Melanoma |
|
Carboplatin |
5.26 | 12040289 16225601 11712820 16342250 |
MESH:D008545 |
Melanoma |
|
Cisplatin |
5.26 | 18505091 12374674 17761969 11135225 16809738 12883367 17023156 18176117 16432458 16248763 15577323 18332650 12393984 |
MESH:D008545 |
Melanoma |
|
Fenretinide |
5.26 | 16270382 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Cisplatin |
4.56 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
4.59 | 16388313 |
MESH:D008654 |
Mesothelioma |
|
Cisplatin |
3.16 | 17638057 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.58 | 16801185 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.04 | 18803445 18765137 |
MESH:D009062 |
Mouth Neoplasms |
|
Fenretinide |
8.41 | 16274795 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
8.41 | 16757204 18986760 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
2.96 | 15949261 14977855 19417148 11468182 19549372 |
MESH:D009137 |
Muscular Dystrophy, Animal |
|
Gentamicins |
6.06 | 18694830 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.84 | 8888407 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.46 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
7.02 | 16882451 16105982 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
7.02 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
alpha-Tocopherol |
4.04 | 19595682 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
3.65 | 18551238 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.76 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
capecitabine |
4.04 | 12972520 |
MESH:D009369 |
Neoplasms |
|
capecitabine |
18.49 | 16374040 |
MESH:D009369 |
Neoplasms |
|
Carboplatin |
18.49 | 18854779 17925555 |
MESH:D009369 |
Neoplasms |
|
Cisplatin |
18.49 | 16773208 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
18.49 | 18854779 |
MESH:D009369 |
Neoplasms |
|
Fenretinide |
18.49 | 15958647 17353921 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
18.49 | 18239605 18600527 16928823 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
bexarotene |
4.57 | 19196722 |
MESH:D009395 |
Nephritis, Interstitial |
|
Cisplatin |
4.28 | 15464296 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.23 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.11 | 18481113 19348381 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
6.88 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
6.88 | 16359493 8888407 |
MESH:D009447 |
Neuroblastoma |
|
Cisplatin |
6.93 | 8761367 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
6.93 | 15176712 8761367 16115947 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Carboplatin |
18.01 | 12837982 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cisplatin |
18.01 | 8761367 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
18.01 | 8761367 12837982 |
MESH:D009472 |
Neuronal Ceroid-Lipofuscinoses |
|
Fenretinide |
5.47 | 16303764 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.30 | 16436463 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
4.13 | 8291058 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
3.25 | 16049721 12819281 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
4.50 | 16517039 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
7.69 | 12452020 16624393 19769630 |
MESH:D010051 |
Ovarian Neoplasms |
|
Cisplatin |
7.69 | 19769630 15464296 6897625 17225452 |
MESH:D010051 |
Ovarian Neoplasms |
|
Fenretinide |
7.69 | 16133793 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
3.46 | 12161096 18093676 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
15.54 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cisplatin |
15.54 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
15.54 | 11332152 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fenretinide |
15.54 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
15.54 | 16929163 19003803 15113037 16500647 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.97 | 19927285 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Cisplatin |
4.11 | 15464296 |
MESH:D010997 |
Pleural Neoplasms |
|
Cisplatin |
5.13 | 17638057 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.05 | 12371664 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
3.69 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
9.02 | 20603192 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
9.02 | 18220299 18042343 19015723 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
4.72 | 18220299 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.20 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
2.20 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fenretinide |
2.20 | 17024972 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
2.20 | 18626508 19082440 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
4.72 | 18629315 |
MESH:D011507 |
Proteinuria |
|
Gentamicins |
4.53 | 15033597 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.33 | 12752131 11422049 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.16 | 16882103 |
MESH:D011657 |
Pulmonary Eosinophilia |
|
alpha-Tocopherol |
5.78 | 14606601 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
3.20 | 16636934 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.83 | 15538739 16160472 18286688 18722050 |
MESH:D051437 |
Renal Insufficiency |
|
Cisplatin |
9.97 | 15464296 |
MESH:D051437 |
Renal Insufficiency |
|
Gentamicins |
9.97 | 17132701 15728788 |
MESH:D012162 |
Retinal Degeneration |
|
Fenretinide |
4.25 | 16303925 |
MESH:D012173 |
Retinitis |
|
Gentamicins |
6.06 | 18644591 |
MESH:D012174 |
Retinitis Pigmentosa |
|
alpha-Tocopherol |
3.91 | 16849425 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
3.98 | 19155313 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
9.67 | 16646077 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Cisplatin |
9.67 | 14601052 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.04 | 15737665 19110320 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
4.63 | 16636934 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
5.47 | 18551238 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
5.47 | 15475178 1511512 17978042 3137016 11738929 14763951 16876388 11044598 |
MESH:D012878 |
Skin Neoplasms |
|
Fenretinide |
3.40 | 16467112 |
MESH:D055752 |
Small Cell Lung Carcinoma |
|
Cisplatin |
5.13 | 15464296 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.30 | 16517039 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.62 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.33 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
3.36 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Cisplatin |
3.36 | 15958060 18396642 17522103 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
3.36 | 17522103 15786421 17498489 17172411 16424979 18567086 16951190 19015929 18396642 19084572 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Carboplatin |
11.77 | 12837982 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
11.77 | 12837982 |
MESH:D013736 |
Testicular Neoplasms |
|
Cisplatin |
4.43 | 15464296 17225452 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
2.93 | 19014326 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
3.81 | 16280240 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.75 | 15213294 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.02 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.31 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
14.96 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
14.96 | 20435036 12973940 12845720 11780464 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cisplatin |
14.96 | 15464296 12973940 17225452 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
14.96 | 14692829 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Fenretinide |
14.96 | 16720286 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.44 | 8888407 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.10 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Cisplatin |
14.98 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fenretinide |
14.98 | 16154183 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
14.98 | 16803524 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.77 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Cisplatin |
4.40 | 15577323 |
MESH:D015837 |
Vestibular Diseases |
|
Gentamicins |
5.32 | 18776599 |
MESH:D014839 |
Vomiting |
|
Cisplatin |
4.51 | 11897121 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.23 | 17120751 |